Literature DB >> 17216557

Hepatitis and rhabdomyolysis in a patient with hormone refractory prostate cancer on ketoconazole and concurrent lovastatin therapy.

C A Stein1, Sanjay Goel, Reza Ghavamian.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17216557     DOI: 10.1007/s10637-006-9032-5

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.651


× No keyword cloud information.
  12 in total

1.  Interaction between lovastatin and cyclosporine A after heart and kidney transplantation.

Authors:  L Gullestad; K P Nordal; K J Berg; H Cheng; M S Schwartz; S Simonsen
Journal:  Transplant Proc       Date:  1999-08       Impact factor: 1.066

2.  Rhabdomyolysis from cytochrome p-450 interaction of ketoconazole and simvastatin in prostate cancer.

Authors:  Haruka Itakura; David Vaughn; Daniel G Haller; Peter J O'Dwyer
Journal:  J Urol       Date:  2003-02       Impact factor: 7.450

3.  Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation.

Authors:  C East; P A Alivizatos; S M Grundy; P H Jones; J A Farmer
Journal:  N Engl J Med       Date:  1988-01-07       Impact factor: 91.245

Review 4.  Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.

Authors:  David Williams; John Feely
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatin.

Authors:  S Grimbert; D Pessayre; C Degott; J P Benhamou
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

Review 6.  Extended clinical safety profile of lovastatin.

Authors:  G Mantell; M T Burke; J Staggers
Journal:  Am J Cardiol       Date:  1990-09-18       Impact factor: 2.778

7.  Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.

Authors:  P J Neuvonen; T Kantola; K T Kivistö
Journal:  Clin Pharmacol Ther       Date:  1998-03       Impact factor: 6.875

8.  Rhabdomyolysis induced by simvastatin and ketoconazole treatment.

Authors:  R Gilad; Y Lampl
Journal:  Clin Neuropharmacol       Date:  1999 Sep-Oct       Impact factor: 1.592

9.  Comparison of midazolam and simvastatin as cytochrome P450 3A probes.

Authors:  Ellen Chung; Anne N Nafziger; David J Kazierad; Joseph S Bertino
Journal:  Clin Pharmacol Ther       Date:  2006-02-28       Impact factor: 6.875

Review 10.  Drug-induced cholestasis.

Authors:  Lakshumanan S Velayudham; Geoffrey C Farrell
Journal:  Expert Opin Drug Saf       Date:  2003-05       Impact factor: 4.250

View more
  1 in total

Review 1.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.